CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Trust but Verify: Importance of Packaging Compendial Testing to Secure the Parenteral Drug Supply Chain

We normally think of trust in the context of our personal relationships with other people, but how often do we consider trust with respect to the products we use? Most of the products used on a daily basis we implicitly trust them to work as advertised because we assume the company providing the product has done sufficient functionality, safety testing and quality control and that there exists somewhere a governmental/regulatory rule requiring testing of said product for human safety by some approved standard before the product can be sold to the consumer. Marc Mittermueller, Flor Toledo Rodriguez and Dan Haines at Schott discuss that for parenteral products, we go one step further with trust, verifying the potentially severe impact to patient safety from counterfeit, mislabelled, mispackaged, defective or non-compliant products.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026